Merck & Co., Inc. (BMV:MRK)
Mexico flag Mexico · Delayed Price · Currency is MXN
2,103.00
-25.01 (-1.18%)
At close: Mar 2, 2026

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of MXN 5.22 trillion. The enterprise value is 5.85 trillion.

Market Cap 5.22T
Enterprise Value 5.85T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date Feb 3, 2026
Ex-Dividend Date Dec 15, 2025

Share Statistics

Current Share Class 2.47B
Shares Outstanding n/a
Shares Change (YoY) -1.34%
Shares Change (QoQ) -0.40%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 79.98%
Float 2.47B

Valuation Ratios

The trailing PE ratio is 15.89 and the forward PE ratio is 23.63.

PE Ratio 15.89
Forward PE 23.63
PS Ratio 4.46
PB Ratio 5.51
P/TBV Ratio 66.73
P/FCF Ratio 23.46
P/OCF Ratio 17.61
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.39, with an EV/FCF ratio of 26.28.

EV / Earnings 17.79
EV / Sales 5.17
EV / EBITDA 11.39
EV / EBIT 13.74
EV / FCF 26.28

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio 1.54
Quick Ratio 0.96
Debt / Equity 0.96
Debt / EBITDA 1.71
Debt / FCF 4.09
Interest Coverage 18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.

Return on Equity (ROE) 36.88%
Return on Assets (ROA) 12.04%
Return on Invested Capital (ROIC) 25.91%
Return on Capital Employed (ROCE) 22.54%
Weighted Average Cost of Capital (WACC) 5.35%
Revenue Per Employee 15.82M
Profits Per Employee 4.44M
Employee Count 75,000
Asset Turnover 0.51
Inventory Turnover 2.32

Taxes

In the past 12 months, Merck & Co. has paid 50.48 billion in taxes.

Income Tax 50.48B
Effective Tax Rate 13.31%

Stock Price Statistics

The stock price has increased by +12.52% in the last 52 weeks. The beta is 0.30, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y) 0.30
52-Week Price Change +12.52%
50-Day Moving Average 1,966.28
200-Day Moving Average 1,674.26
Relative Strength Index (RSI) 57.56
Average Volume (20 Days) 2,060

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.09

Income Statement

In the last 12 months, Merck & Co. had revenue of MXN 1.17 trillion and earned 328.63 billion in profits. Earnings per share was 131.06.

Revenue 1.17T
Gross Profit 903.69B
Operating Income 440.48B
Pretax Income 379.27B
Net Income 328.63B
EBITDA 523.98B
EBIT 440.48B
Earnings Per Share (EPS) 131.06
Full Income Statement

Balance Sheet

The company has 262.22 billion in cash and 909.77 billion in debt, with a net cash position of -647.56 billion.

Cash & Cash Equivalents 262.22B
Total Debt 909.77B
Net Cash -647.56B
Net Cash Per Share n/a
Equity (Book Value) 948.08B
Book Value Per Share 382.71
Working Capital 273.45B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 296.55 billion and capital expenditures -74.03 billion, giving a free cash flow of 222.52 billion.

Operating Cash Flow 296.55B
Capital Expenditures -74.03B
Free Cash Flow 222.52B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin 77.21%
Operating Margin 37.64%
Pretax Margin 32.41%
Profit Margin 28.08%
EBITDA Margin 44.77%
EBIT Margin 37.64%
FCF Margin 19.01%

Dividends & Yields

This stock pays an annual dividend of 61.71, which amounts to a dividend yield of 2.93%.

Dividend Per Share 61.71
Dividend Yield 2.93%
Dividend Growth (YoY) 5.97%
Years of Dividend Growth 2
Payout Ratio 47.09%
Buyback Yield 1.34%
Shareholder Yield 4.25%
Earnings Yield 6.29%
FCF Yield 4.26%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score 3.5
Piotroski F-Score 5